Molecular Activation of the NLRP3 Inflammasome in Fibrosis: Common Threads Linking Divergent Fibrogenic Diseases

Antioxidants and Redox Signaling

Volumn 22, Issue 13, 2015, Pages 1162-1175

  Artlett, Carol M ^a   Thacker, James D ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b TherimuneX Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REACTIVE OXYGEN METABOLITE; CALCIUM; CARRIER PROTEIN; INFLAMMASOME; NLRP3 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL ADHESION; CELL DIFFERENTIATION; CELL SURVIVAL; COLLAGEN SYNTHESIS; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROSIS; HUMAN; MESANGIUM CELL; MESENCHYME CELL; MYOFIBROBLAST; NONHUMAN; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; LUNG; METABOLISM; PATHOLOGY; SKIN;

CALCIUM; CARRIER PROTEINS; ENDOPLASMIC RETICULUM STRESS; FIBROSIS; HUMANS; INFLAMMASOMES; LUNG; NADPH OXIDASE; REACTIVE OXYGEN SPECIES; SKIN;

EID: 84934343580     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6148     Document Type: Review

References (120)

1. Amara N, Goven D, Prost F, Muloway R, Crestani B, and Boczkowski J. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1- induced fibroblast differentiation into myofibroblasts. Thorax 65: 733-738, 2010.
2. Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali- Bostwick CA, and Katsikis PD. The inflammasome activating caspase-1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum 63: 3563-3574, 2011.
3. Barbiero G, Munaron L, Antoniotti S, Baccino FM, Bonelli G, and Lovisolo D. Role of mitogen-induced calcium influx in the control of the cell cycle in Balb-c 3T3 fibroblasts. Cell Calcium 18: 542-556, 1995.
4. Bell JK, Botos I, Hall PR, Askins J, Shiloach J, Segal DM, and Davies DR. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci U S A 102: 10976-10980, 2005.
5. Bella J, Hindle KL, McEwan PA, and Lovell SC. The leucine-rich repeat structure. Cell Mol Life Sci 65: 2307-2333, 2008.
6. Black CM, Welsh KI, Walker AE, Bernstein RM, Catoggio LJ, McGregor AR, and Lloyd Jones JK. Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet 1: 53-55, 1983.
7. Brough D, Le Feuvre RA, Wheeler RD, Solovyova N, Hilfiker S, Rothwell NJ, and Verkhratsky A. Ca2 + stores and Ca2 + entry differentially contribute to the release of IL-1 beta and IL-1 alpha from murine macrophages. J Immunol 170: 3029-3036, 2003.
8. Cassel SL, Eisenbarth SC, Lyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, and Sutterwala FS. The NALP3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 105: 9035-9040, 2008.
9. Clapham DE. Calcium signaling. Cell 131: 1047-1058, 2007.
10. Couillin I, Vasseur V, Charron S, Gasse P, Tavernier M, Guillet J, Lagente V, Fick L, Jacobs M, Coelho FR, Moser R, and Ryffel B. IL-1R1/MyD88 signaling is critical for elastase-induced lung inflammation and emphysema. J Immunol 183: 8195-8202, 2009.
11. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, and Sorescu D. NAD(P)H oxidase 4 mediates transforming growth factor-á1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res 97: 900-907, 2005.
12. Dai X, Sayama K, Tohyama M, Shirakata Y, Hanakawa Y, Tokumaru S, Yang L, Hirakawa S, and Hashimoto K. Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J Allergy Clin Immunol 127: 806-814, 2011.
13. Dhainaut JF, Charpentier J, and Chiche JD. Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 31: S258-S264, 2003.
14. Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann N Y Acad Sci 856: 1-11, 1998.
15. Dinarello CA. Interleukin-18. Methods 19: 121-132, 1999.
16. Dostert C, Petrilli V, van Bruggen R, Steele C, Mossman BT, and Tschopp J. Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science 320: 674-677, 2008.
17. Failli P, Palmieri L, D'Alfonso C, Giovannelli L, Generini S, Rosso AD, Pignone A, Stanflin N, Orsi S, Zilletti L, and Matucci-Cerinic M. Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric Oxide 7: 277-282, 2002.
18. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, and Beer HD. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17: 1140-1145, 2007.
19. Fernandez-Velasco M, Prieto P, Terron V, Benito G, Flores JM, Delgado C, Zaragoza C, Lavin B, Gomez- Parrizas M, Lopez-Collazo E, Martin-Sanz P, and Bosca L. NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis. PLoS One 7: e45260, 2012.
20. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M, Panther E, and Di VF. The P2X7 receptor: a key player in IL-1 processing and release. J Immunol 176: 3877-3883, 2006.
21. Fiaschi T, Magherini F, Gamberi T, Lucchese G, Faggian G, Modesti A, and Modesti PA. Hyperglycemia and angiotensin II cooperate to enhance collagen I deposition by cardiac fibroblasts through a ROS-STAT3-dependent mechanism. Biochim Biophys Acta 1843: 2603-2610, 2014.
22. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172, 2008.
23. Gadek-Michalska A and Bugajski J. Interleukin-1 (IL-1) in stress-induced activation of limbic-hypothalamic-pituitary adrenal axis. Pharmacol Rep 62: 969-982, 2010.
24. Gasse P, Mary C, Guenon I, Noulin N, Charron S, Schnyder-Candrian S, Schnyder B, Akira S, Quesniaux VFJ, Lagente V, Ryffel B, and Couillin I. IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice. J Clin Invest 117: 3786-3799, 2007.
25. Gasse P, Riteau N, Charron S, Girre S, Fick L, Petrilli V, Tschopp J, Lagente V, Quesniaux VF, Ryffel B, and Couillin I. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am J Respir Crit Care Med 179: 903-913, 2009.
26. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, and Abboud HE. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626, 2005.
27. Goy C, Czypiorski P, Altschmied J, Jakob S, Rabanter LL, Brewer AC, Ale-Agha N, Dyballa-Rukes N, Shah AM, and Haendeler J. The imbalanced redox status in senescent endothelial cells is due to dysregulated thioredoxin-1 and NADPH oxidase 4. Exp Gerontol 56: 45-52, 2014.
28. Greenhalgh SN, Iredale JP, and Henderson NC. Origins of fibrosis: pericytes take centre stage. F1000 Prime Rep 5: 37, 2013.
29. Haustein UF and Herrmann K. Environmental scleroderma. Clin Dermatol 12: 467-473, 1994.
30. Haustein UF, Ziegler V, and Herrmann K. Chemicallyinduced scleroderma. Hautarzt 43: 469-474, 1992.
31. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, and Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081, 2009.
32. Heid ME, Keyel PA, Kamga C, Shiva S, Watkins SC, and Salter RD. Mitochondrial reactive oxygen species induces NLRP3-dependent lysosomal damage and inflammasome activation. J Immunol 191: 5230-5238, 2013.
33. Hindle KL, Bella J, and Lovell SC. Quantitative analysis and prediction of curvature in leucine-rich repeat proteins. Proteins 77: 342-358, 2009.
34. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, and Thannickal VJ. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 19: 761-771, 2007.
35. Inohara N and Nunez G. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 20: 6473-6481, 2001.
36. Inohara N and Nunez G. NODS: intracellualr proteins involved in inflammation and apoptosis. Nat Rev 3: 371-382, 2003.
37. Janssen LJ, Farkas L, Rahman T, and Kolb MR. ATP stimulates Ca(2 + )-waves and gene expression in cultured human pulmonary fibroblasts. Int J Biochem Cell Biol 41: 2477-2484, 2009.
38. Jia Y, Xu J, Yu Y, Guo J, Liu P, Chen S, and Jiang J. Nifedipine inhibits angiotensin II-induced cardiac fibrosis via downregulating Nox4-derived ROS generation and suppressing ERK1/2, JNK signaling pathways. Die Pharm 68: 435-441, 2013.
39. Jiang F, Liu GS, Dusting GJ, and Chan EC. NADPH oxidase-dependent redox signaling in TGF-beta-mediated fibrotic responses. Redox Biol 2: 267-272, 2014.
40. Jiang JX, Chen X, Serizawa N, Szyndralewiez C, Page P, Schroder K, Brandes RP, Devaraj S, and Torok NJ. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic Biol Med 53: 289-296, 2012.
41. Kanneganti TD, Lamkanfi M, and Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 27: 549-559, 2007.
42. Kao JP, Alderton JM, Tsien RY, and Steinhardt RA. Active involvement of Ca2 + in mitotic progression of Swiss 3T3 fibroblasts. J Cell Biol 111: 183-196, 1990.
43. Kaur G, Sharma A, Guruprasad K, and Pati PK. Versatile roles of plant NADPH oxidases and emerging concepts. Biotechnol Adv 32: 551-563, 2014.
44. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, and Ikeda U. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123: 594-604, 2011.
45. Keller M, Ruegg A, Werner S, and Beer HD. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132: 818-831, 2008.
46. Kisseleva T and Brenner DA. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J Hepatol 56: 965-972, 2012.
47. Kojima N, Hori M, Murata T, Morizane Y, and Ozaki H. Different profiles of Ca2 + responses to endothelin-1 and PDGF in liver myofibroblasts during the process of cell differentiation. Br J Pharmacol 151: 816-827, 2007.
48. Kolb M, Margetts PJ, Anthony DC, Pitossi F, and Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest 107: 1529-1536, 2001.
49. Krebs J, Groenendyk J, and Michalak M. Ca2 + -signaling, alternative splicing and endoplasmic reticulum stress responses. Neurochem Res 36: 1198-1211, 2011.
50. Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, and Mills KH. Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J Immunol 186: 5738-5748, 2011.
51. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, and Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19: 1047-1053, 2013.
52. Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, Sacks DB, Germain RN, Kastner DL, and Chae JJ. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2 + and cAMP. Nature 492: 123-127, 2012.
53. Lekkerkerker AN, Aarbiou J, van Es T, and Janssen RA. Cellular players in lung fibrosis. Curr Pharm Des 18: 4093-4102, 2012.
54. Lemasters JJ, Theruvath TP, Zhong Z, and Nieminen AL. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 1787: 1395-1401, 2009.
55. Li C and Kuemmerle JF. Mechanisms that mediate the development of fibrosis in patients with Crohn's disease. Inflamm Bowel Dis 20: 1250-1258, 2014.
56. Li F, Thiele I, Jamshidi N, and Palsson BO. Identification of potential pathway mediation targets in Toll-like receptor signaling. PLoS Comp Biol 5: e1000292, 2009.
57. Liaudet L and Rosenblatt-Velin N. Role of innate immunity in cardiac inflammation after myocardial infarction. Front Biosci 5: 86-104, 2013.
58. Liu W, Yin Y, Zhou Z, He M, and Dai Y. OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation. Inflamm Res 63: 33-43, 2014.
59. Loughlin DT and Artlett CM. 3-deoxyglucosone-collagen alters human dermal fibroblast migration and adhesion: implications for impaired wound healing in patients with diabetes. Wound Repair Regen 17: 739-749, 2009.
60. Loughlin DT and Artlett CM. Precursor of advanced glycation end products mediates ER-stress-induced caspase- 3 activation of human dermal fibroblasts through NAD(P)H oxidase 4. PLoS One 5: e11093, 2010.
61. Lua I, James D, Wang J, Wang KS, and Asahina K. Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury. Hepatology 60: 311-322, 2014.
62. Marchi S, Patergnani S, and Pinton P. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim Biophys Acta 1837: 461-469, 2014.
63. Martinon F and Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26: 447-454, 2005.
64. Maslen CL, Hall ND, Woolf AD, and Maddison PJ. Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis. Br J Rheumatol 26: 113-117, 1987.
65. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nunez G, Yodoi J, Kahn SE, Lavelle EC, and O'Neill LA. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11: 897-904, 2010.
66. Matsuo J, Tsukumo Y, Sakurai J, Tsukahara S, Park HR, Shin-ya K, Watanabe T, Tsuruo T, and Tomida A. Preventing the unfolded protein response via aberrant activation of 4E-binding protein 1 by versipelostatin. Cancer Sci 100: 327-333, 2009.
67. Menu P, Mayor A, Zhou R, Tardivel A, Ichijo H, Mori K, and Tschopp J. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis 3: e261, 2012.
68. Montorfano I, Becerra A, Cerro R, Echeverria C, Saez E, Morales MG, Fernandez R, Cabello-Verrugio C, and Simon F. Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-beta1 and TGF-beta2- dependent pathway. Lab Invest 94: 1068-1082, 2014.
69. Mu YP, Ogawa T, and Kawada N. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet. Lab Invest 90: 245-256, 2010.
70. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, and Horng T. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A 109: 11282-11287, 2012.
71. Murrell DF. A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 28: 78-85, 1993.
72. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, Fitzgerald KA, Ryter SW, and Choi AM. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230, 2011.
73. Ngo MA, Muller A, Li Y, Neumann S, Tian G, Dixon IM, Arora RC, and Freed DH. Human mesenchymal stem cells express a myofibroblastic phenotype in vitro: comparison to human cardiac myofibroblasts. Mol Cell Biochem 392: 187-204, 2014.
74. Nishitoh H. CHOP is a multifunctional transcription factor in the ER stress response. J Biochem 151: 217-219, 2012.
75. Ohyama T, Sato K, Kishimoto K, Yamazaki Y, Horiguchi N, Ichikawa T, Kakizaki S, Takagi H, Izumi T, and Mori M. Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence. Br J Pharmacol 165: 1173-1187, 2012.
76. Oslowski CM, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S, Hara M, Ishigaki S, Zhu LJ, Hayashi E, Hui ST, Greiner D, Kaufman RJ, Bortell R, and Urano F. Thioredoxin- interacting protein mediates ER stress-induced beta cell death through initiation of the inflammasome. Cell Metab 16: 265-273, 2012.
77. Osuka A, Hanschen M, Stoecklein V, and Lederer JA. A protective role for inflammasome activation following injury. Shock 37: 47-55, 2012.
78. Overley-Adamson B, Artlett CM, Stephens C, Sassi-Gaha S, Weis RD, and Thacker JD. Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancer. Cancer Biol Ther 15: 452-462, 2014.
79. Pan SY, Chang YT, and Lin SL. Microvascular pericytes in healthy and diseased kidneys. Int J Nephrol Renovas Dis 7: 39-48, 2014.
80. Parajuli B, Sonobe Y, Horiuchi H, Takeuchi H, Mizuno T, and Suzumura A. Oligomeric amyloid beta induces IL- 1beta processing via production of ROS: implication in Alzheimer's disease. Cell Death Dis 4: e975, 2013.
81. Phan SH, Zhang K, Zhang HY, and Gharaee-Kermani M. The myofibroblast as an inflammatory cell in pulmonary fibrosis. Curr Top Pathol 93: 173-182, 1999.
82. Platis A, Yu Q, Moore D, Khojeini E, Tsau P, and Larson D. The effect of daily administration of IL-18 on cardiac structure and function. Perfusion 23: 237-242, 2008.
83. Ramm GA, Carr SC, Bridle KR, Li L, Britton RS, Crawford DH, Vogler CA, Bacon BR, and Tracy TF. Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts. Liver 20: 387-396, 2000.
84. Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, and Gabrielli A. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 44: 2653-2664, 2001.
85. Sampson N, Berger P, and Zenzmaier C. Redox signaling as a therapeutic target to inhibit myofibroblast activation in degenerative fibrotic disease. Biomed Res Int 2014: 131737, 2014.
86. Sassi-Gaha S, Loughlin DT, Kappler F, Schwartz ML, Su B, Tobia AM, and Artlett CM. Two Dicarbonyl compounds, 3- deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblasts. Matrix Biol 29: 127-134, 2010.
87. Sciarretta S, Volpe M, and Sadoshima J. NOX4 regulates autophagy during energy deprivation. Autophagy 10: 699-701, 2014.
88. Shah A, Xia L, Goldberg H, Lee KW, Quaggin SE, and Fantus IG. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J Biol Chem 288: 6835-6848, 2013.
89. Shalhoub J, Falck-Hansen MA, Davies AH, and Monaco C. Innate immunity and monocyte-macrophage activation in atherosclerosis. J Inflamm 8: 9, 2011.
90. Smith RS, Smith TJ, Blieden TM, and Phipps RP. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 151: 317-322, 1997.
91. Stefanovic B, Stefanovic L, Schnabl B, Bataller R, and Brenner DA. TRAM2 protein interacts with endoplasmic reticulum Ca2 + pump Serca2b and is necessary for collagen type I synthesis. Mol Cell Biol 24: 1758-1768, 2004.
92. Sugawara S, Uehara A, Nochi T, Yamaguchi T, Ueda H, Sugiyama A, Hanzawa K, Kumagai K, Okamura H, and Takada H. Neutrophil proteinase 3-mediated induction of bioactive IL-18 secretion by human oral epithelial cells. J Immunol 167: 6568-6575, 2001.
93. Teshima Y, Takahashi N, Nishio S, Saito S, Kondo H, Fukui A, Aoki K, Yufu K, Nakagawa M, and Saikawa T. Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. Circ J 78: 300-306, 2014.
94. Thacker JD, Balin BJ, Appelt DM, Sassi-Gaha S, Purohit M, Rest RF, and Artlett CM. NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugs. Antimicrob Agents Chemother 56: 1921-1930, 2012.
95. Thacker JD, BrownMA, Rest RF, Purohit M, Sassi-Gaha S, and Artlett CM. 1-peptidyl-2-arachidonoyl-3-stearoyl-snglyceride: an immunologically active lipopeptide from goat serum (Capra hircus) is an endogenous damage associated molecular pattern. J Nat Prod 72: 1993-1999, 2009.
96. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, and Thomas PE. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 278: 12384-12389, 2003.
97. Thomay AA, Daley JM, Sabo E, Worth PJ, Shelton LJ, Harty MW, Reichner JS, and Albina JE. Disruption of interleukin-1 signaling improves the quality of wound healing. Am J Pathol 174: 2129-2136, 2009.
98. van Bruggen R, Koker MY, Jansen M, van Houdt M, Roos D, Kuijpers TW, and van den Berg TK. Human NLRP3 inflammasome activation is Nox1-4 independent. Blood 115: 5398-5400, 2010.
99. Van De Water L, Varney S, and Tomasek JJ. Mechanoregulation of the Myofibroblast in Wound Contraction, Scarring, and Fibrosis: Opportunities for New Therapeutic Intervention. Adv Wound Care 2: 122-141, 2013.
100. Vyas-Read S, Wang W, Kato S, Colvocoresses-Dodds J, Fifadara NH, Gauthier TW, Helms MN, Carlton DP, and Brown LA. Hyperoxia induces alveolar epithelial-tomesenchymal cell transition. Am J Physiol Lung Cell Mol Physiol 306: L326-L340, 2014.
101. Wang L, Hartmann P, Haimerl M, Bathena SP, Sjowall C, Almer S, Alnouti Y, Hofmann AF, and Schnabl B. Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids. J Hepatol 60: 1259-1267, 2014.
102. Wang Y, Wu Y, Chen J, Zhao S, and Li H. Pirfenidone attenuates cardiac fibrosis in a mouse model of TACinduced left ventricular remodeling by suppressing NLRP3 inflammasome formation. Cardiology 126: 1-11, 2013.
103. Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, Mahmood S, Jhandier MN, Shi Y, Flavell RA, and Mehal WZ. Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 296: G1248-G1257, 2009.
104. West AP, Shadel GS, and Ghosh S. Mitochondria in innate immune responses. Nat Rev Immunol 11: 389-402, 2011.
105. Wilson KP, Black JA, Thomson JA, Kim EE, Griffith JP, Navia MA, Murcko MA, Chambers SP, Aldape RA, and Raybuck SA. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370: 270-275, 1994.
106. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210, 2008.
107. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350, 2011.
108. Xing SS, Tan HW, Bi XP, Zhong M, Zhang Y, and Zhang W. Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats. Mol Med 14: 395-402, 2008.
109. Yang HC, Cheng ML, Ho HY, and Chiu DT. The microbicidal and cytoregulatory roles of NADPH oxidases. Microbes Infect 13: 109-120, 2011.
110. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, and Yang XF. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 22: 311-322, 2009.
111. Yoshida H, Matsui T, Yamamoto A, Okada T, and Mori K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107: 881-891, 2001.
112. Yoshida H, Oku M, Suzuki M, and Mori K. pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response. J Cell Biol 172: 565-575, 2006.
113. Yu Q, Vazquez R, Khojeini EV, Patel C, Venkataramani R, and Larson DF. IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am J Physiol Heart Circ Physiol 297: H76-H85, 2009.
114. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, and Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107, 2010.
115. Zhang Y, Yang J, Jiang S, Fang C, Xiong L, Cheng H, and Xia Y. The lupus-derived anti-double-stranded DNA IgG contributes to myofibroblast-like phenotype in mesangial cells. J Clin Immunol 32: 1270-1278, 2012.
116. Zhong Z, Zhai Y, Liang S, Mori Y, Han R, Sutterwala FS, and Qiao L. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun 4: 1611, 2013.
117. Zhou CF, Zhou DC, Zhang JX, Wang F, Cha WS, Wu CH, and Zhu QX. Bleomycin-induced epithelial-mesenchymal transition in sclerotic skin of mice: Possible role of oxidative stress in the pathogenesis. Toxicol Appl Pharmacol 277: 250-258, 2014.
118. Zhou R, Tardivel A, Thorens B, Choi I, and Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010.
119. Zhou R, Yazdi AS, Menu P, and Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.
120. Zong J, Salim M, Zhou H, Bian ZY, Dai J, Yuan Y, Deng W, Zhang JY, Zhang R, Wu QQ, and Tang QZ. NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload. Lab Invest 93: 1128-1136, 2013.